Artificial intelligence (AI) in Medical Diagnostics Market: Current Analysis and Forecast (2025-2033)

Artificial Intelligence (AI) in Medical Diagnostics Market Size & Forecast

Artificial Intelligence (AI) in the Medical Diagnostics market was valued at approximately USD 1.36 billion in 2024 and is expected to grow at a substantial CAGR of around 28% during the forecast period (2025-2033), owing to the rising prevalence of chronic diseases and the number of hospitalizations has forced medical institutions to develop and introduce advanced diagnostic facilities.

Artificial Intelligence (AI) in Medical Diagnostics Market Analysis

Artificial intelligence (AI) uses computer programs that analyze very large amounts of information to learn how to help make decisions or predictions. AI has revolutionized the healthcare sector due to its faster and more accurate decision-making. The rising prevalence of chronic diseases and the number of hospitalizations have forced medical institutions to develop and introduce advanced diagnostic facilities. Furthermore, the rapidly rising geriatric population and increasing age-related diseases among them contribute to the market growth of AI in medical diagnostics for fast and accurate diagnosis. Furthermore, the continuous development of medical visualization techniques is also responsible for the market growth of AI in medical diagnostics. 

Artificial Intelligence (AI) in Medical Diagnostics Market Trends

This section discusses the key market trends influencing the various segments of Artificial Intelligence (AI) in the Medical Diagnostics market as identified by our research experts.

Integration of Multimodal Data for Enhanced Diagnostic Accuracy

One of the key trends observed in the AI in medical diagnostics area is the use of multi-modal data that includes radiology images, pathology slides, genomic data, and EHRs to enhance the accuracy of the results. Different data sources are being used in AI models to gain a better understanding of the patient’s health status. This approach improves the assessment of the probability of patients’ diseases, identification of diseases at early stages, and individual planning of treatment courses, including oncology, neurology, and cardiology. The continuous incorporation of multimodal AI solutions is shifting diagnostics from a reactive to a preventive model, making it a benchmark for any current and future health care service delivery.

Artificial Intelligence (AI) in Medical Diagnostics Industry Segmentation

This section provides an analysis of the key trends in each segment of the global Artificial Intelligence (AI) in Medical Diagnostics market report, along with forecasts at the global, regional, and country levels for 2025-2033.

The Software Segment Holds the Largest Share of Artificial Intelligence (AI) in the Medical Diagnostics Market.

Based on component, the market is categorized into software and services. The software segment held a significant market share in 2024, and it is anticipated to grow during the forecast period. The rapidly increasing number of cases of infectious diseases imposes a burden on the medical diagnostic facilities for testing, which in turn increases the demand for software-based AIs for diagnosis and fast analysis of the results. For instance, as per the WHO, the global incidence of dengue has grown dramatically, with about half of the world's population now at risk. It is estimated that 100-400 million infections occur each year. 

The In Vitro Segment is Expected to Witness a Higher CAGR of Artificial Intelligence (AI) in the Medical Diagnostics Market.

Based on application, the market is segmented into in vivo and in vitro. In vivo held a significant market share in 2024 and is anticipated to witness significant growth during the forecast period. This is mainly due to the increasing prevalence of chronic diseases and the rising maternity complications that contribute to the significant market growth of the in vivo segment in the AI-based diagnostic market. For instance, as per the WHO, every day, 800 women die from complications of childbirth, and a pregnant woman from a developing country is 36 times more likely to suffer from pregnancy-related complications compared with a pregnant woman from a developed country.  

North America has a significant share of the market in 2024.

North America grabbed a significant market share of the global artificial intelligence (AI) in the medical diagnostics market in 2024. It is expected to grow with considerable CAGR during the forecast period. The major factors, such as favorable government initiatives, sophisticated healthcare infrastructure, the presence of a large geriatric population, and the rise in chronic disease incidences across the region, are propelling the growth of this market. For instance, the number of Americans aged 60 and older increased by 34% from 55.7 million to 74.6 million between 2009 and 2019. Also, 133 million Americans, i.e., 45% of the population, have at least one chronic disease. In addition to this, Chronic diseases are responsible for seven out of every 10 deaths in the U.S., killing more than 1.7 million Americans every year. 

U.S. Dominates the North American Artificial Intelligence (AI) in Medical Diagnostics Market

AI in the medical diagnostics market in the U.S. is growing at a fast pace due to innovative technology, an increase in the need for early diagnosis, and the availability of large medical data. Most of the medical facilities and tech industries are actively using AI tools in the processes of radiology, pathology, and diagnostic imaging to minimize human errors and improve patient care. The U.S has another added advantage in the following factors: there is a supportive regulatory environment, there is increased healthcare spending, and the nation boasts excellent digital health systems to accommodate the AI diagnostic solutions.

Artificial Intelligence (AI) in the Medical Diagnostics Industry Competitive Landscape  

The Artificial Intelligence (AI) in Medical Diagnostics market is competitive, with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions.

Top Companies in Artificial Intelligence (AI) in Medical Diagnostics

Some of the major players operating in the market are Siemens Healthineers; Zebra Medical Vision Inc. (Nanox Imaging); Riverain Technologies; Vuno Inc.; Aidoc; Neural Analytics (NovaSignal Corp); Imagen Technologies; Digital Diagnostics Inc.; GE Healthcare; and AliveCor Inc.

Recent Developments in Artificial Intelligence (AI) in the Medical Diagnostics Market

• In July 2024, AWS and GE HealthCare collaborated to enhance healthcare outcomes by leveraging industry-specific AI foundation models (FMs) and innovative applications. This partnership aims to unlock critical healthcare information, paving the way for advanced wellness solutions.

• In October 2023, NeuraSignal acquired NovaSignal, the original developer of the NovaGuide system. This robot-assisted transcranial Doppler (raTCD) system operates without human direction for data acquisition, potentially increasing access to critical data for clinicians to detect right-to-left shunt (RLS).

Artificial Intelligence (AI) in Medical Diagnostics Market Report Coverage

Reasons to Buy Artificial Intelligence (AI) in Medical Diagnostics Market Report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

• The report presents a quick review of overall industry performance at a glance.

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

• The study comprehensively covers the market across different segments.

• Deep dive regional-level analysis of the industry.

Customization Options:

The global Artificial Intelligence (AI) in Medical Diagnostics market can be customized further as per the requirement or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.